![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SERPINF1 |
Gene summary for SERPINF1 |
![]() |
Gene information | Species | Human | Gene symbol | SERPINF1 | Gene ID | 5176 |
Gene name | serpin family F member 1 | |
Gene Alias | EPC-1 | |
Cytomap | 17p13.3 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | A0A140VKF3 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
5176 | SERPINF1 | AEH-subject1 | Human | Endometrium | AEH | 2.14e-27 | -8.02e-01 | -0.3059 |
5176 | SERPINF1 | AEH-subject2 | Human | Endometrium | AEH | 3.89e-36 | -8.76e-01 | -0.2525 |
5176 | SERPINF1 | AEH-subject3 | Human | Endometrium | AEH | 1.42e-27 | -7.63e-01 | -0.2576 |
5176 | SERPINF1 | AEH-subject4 | Human | Endometrium | AEH | 1.30e-21 | -8.05e-01 | -0.2657 |
5176 | SERPINF1 | AEH-subject5 | Human | Endometrium | AEH | 1.37e-41 | -8.84e-01 | -0.2953 |
5176 | SERPINF1 | EEC-subject1 | Human | Endometrium | EEC | 3.66e-42 | -8.67e-01 | -0.2682 |
5176 | SERPINF1 | EEC-subject2 | Human | Endometrium | EEC | 1.29e-38 | -8.66e-01 | -0.2607 |
5176 | SERPINF1 | EEC-subject3 | Human | Endometrium | EEC | 1.43e-41 | -8.43e-01 | -0.2525 |
5176 | SERPINF1 | EEC-subject4 | Human | Endometrium | EEC | 6.89e-26 | -7.33e-01 | -0.2571 |
5176 | SERPINF1 | EEC-subject5 | Human | Endometrium | EEC | 8.07e-27 | -7.72e-01 | -0.249 |
5176 | SERPINF1 | GSM5276935 | Human | Endometrium | EEC | 5.63e-17 | -6.25e-01 | -0.123 |
5176 | SERPINF1 | GSM6177620_NYU_UCEC1_lib1_lib1 | Human | Endometrium | EEC | 1.25e-29 | -8.58e-01 | -0.1869 |
5176 | SERPINF1 | GSM6177620_NYU_UCEC1_lib2_lib2 | Human | Endometrium | EEC | 2.64e-27 | -8.63e-01 | -0.1875 |
5176 | SERPINF1 | GSM6177620_NYU_UCEC1_lib3_lib3 | Human | Endometrium | EEC | 3.13e-31 | -8.51e-01 | -0.1883 |
5176 | SERPINF1 | GSM6177621_NYU_UCEC2_lib1_lib1 | Human | Endometrium | EEC | 2.59e-25 | -7.02e-01 | -0.1934 |
5176 | SERPINF1 | GSM6177622_NYU_UCEC3_lib1_lib1 | Human | Endometrium | EEC | 1.42e-32 | -7.44e-01 | -0.1917 |
5176 | SERPINF1 | GSM6177622_NYU_UCEC3_lib2_lib2 | Human | Endometrium | EEC | 4.53e-32 | -7.76e-01 | -0.1916 |
5176 | SERPINF1 | LZE2T | Human | Esophagus | ESCC | 1.68e-15 | 1.31e+00 | 0.082 |
5176 | SERPINF1 | LZE4T | Human | Esophagus | ESCC | 1.90e-08 | 5.25e-01 | 0.0811 |
5176 | SERPINF1 | P1T-E | Human | Esophagus | ESCC | 9.43e-03 | 4.78e-01 | 0.0875 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:005127113 | Endometrium | EEC | negative regulation of cellular component movement | 72/2168 | 367/18723 | 4.59e-06 | 1.15e-04 | 72 |
GO:001063215 | Endometrium | EEC | regulation of epithelial cell migration | 60/2168 | 292/18723 | 6.37e-06 | 1.52e-04 | 60 |
GO:003033612 | Endometrium | EEC | negative regulation of cell migration | 67/2168 | 344/18723 | 1.24e-05 | 2.54e-04 | 67 |
GO:004001312 | Endometrium | EEC | negative regulation of locomotion | 74/2168 | 391/18723 | 1.28e-05 | 2.59e-04 | 74 |
GO:007138315 | Endometrium | EEC | cellular response to steroid hormone stimulus | 45/2168 | 204/18723 | 1.40e-05 | 2.79e-04 | 45 |
GO:000182212 | Endometrium | EEC | kidney development | 59/2168 | 293/18723 | 1.44e-05 | 2.87e-04 | 59 |
GO:000756815 | Endometrium | EEC | aging | 66/2168 | 339/18723 | 1.46e-05 | 2.87e-04 | 66 |
GO:005134615 | Endometrium | EEC | negative regulation of hydrolase activity | 72/2168 | 379/18723 | 1.46e-05 | 2.87e-04 | 72 |
GO:005067814 | Endometrium | EEC | regulation of epithelial cell proliferation | 72/2168 | 381/18723 | 1.76e-05 | 3.33e-04 | 72 |
GO:004354213 | Endometrium | EEC | endothelial cell migration | 55/2168 | 279/18723 | 5.12e-05 | 8.18e-04 | 55 |
GO:001097513 | Endometrium | EEC | regulation of neuron projection development | 79/2168 | 445/18723 | 6.80e-05 | 1.01e-03 | 79 |
GO:003196015 | Endometrium | EEC | response to corticosteroid | 37/2168 | 167/18723 | 7.08e-05 | 1.04e-03 | 37 |
GO:001059412 | Endometrium | EEC | regulation of endothelial cell migration | 47/2168 | 232/18723 | 8.81e-05 | 1.25e-03 | 47 |
GO:005138415 | Endometrium | EEC | response to glucocorticoid | 33/2168 | 148/18723 | 1.50e-04 | 1.90e-03 | 33 |
GO:001072012 | Endometrium | EEC | positive regulation of cell development | 56/2168 | 298/18723 | 1.68e-04 | 2.10e-03 | 56 |
GO:00426981 | Endometrium | EEC | ovulation cycle | 19/2168 | 68/18723 | 1.84e-04 | 2.26e-03 | 19 |
GO:001003817 | Endometrium | EEC | response to metal ion | 66/2168 | 373/18723 | 2.86e-04 | 3.23e-03 | 66 |
GO:001046615 | Endometrium | EEC | negative regulation of peptidase activity | 49/2168 | 262/18723 | 4.64e-04 | 4.79e-03 | 49 |
GO:001095114 | Endometrium | EEC | negative regulation of endopeptidase activity | 47/2168 | 252/18723 | 6.37e-04 | 6.25e-03 | 47 |
GO:003134613 | Endometrium | EEC | positive regulation of cell projection organization | 61/2168 | 353/18723 | 8.82e-04 | 8.03e-03 | 61 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0431010 | Endometrium | AEH | Wnt signaling pathway | 37/1197 | 171/8465 | 4.68e-03 | 2.53e-02 | 1.86e-02 | 37 |
hsa0431013 | Endometrium | AEH | Wnt signaling pathway | 37/1197 | 171/8465 | 4.68e-03 | 2.53e-02 | 1.86e-02 | 37 |
hsa0431022 | Endometrium | EEC | Wnt signaling pathway | 40/1237 | 171/8465 | 1.37e-03 | 8.99e-03 | 6.70e-03 | 40 |
hsa0431032 | Endometrium | EEC | Wnt signaling pathway | 40/1237 | 171/8465 | 1.37e-03 | 8.99e-03 | 6.70e-03 | 40 |
hsa0431016 | Oral cavity | EOLP | Wnt signaling pathway | 37/1218 | 171/8465 | 6.23e-03 | 1.83e-02 | 1.08e-02 | 37 |
hsa0431017 | Oral cavity | EOLP | Wnt signaling pathway | 37/1218 | 171/8465 | 6.23e-03 | 1.83e-02 | 1.08e-02 | 37 |
hsa0431024 | Oral cavity | NEOLP | Wnt signaling pathway | 34/1112 | 171/8465 | 8.05e-03 | 2.88e-02 | 1.81e-02 | 34 |
hsa0431034 | Oral cavity | NEOLP | Wnt signaling pathway | 34/1112 | 171/8465 | 8.05e-03 | 2.88e-02 | 1.81e-02 | 34 |
hsa0431014 | Prostate | BPH | Wnt signaling pathway | 50/1718 | 171/8465 | 3.11e-03 | 1.15e-02 | 7.14e-03 | 50 |
hsa0431015 | Prostate | BPH | Wnt signaling pathway | 50/1718 | 171/8465 | 3.11e-03 | 1.15e-02 | 7.14e-03 | 50 |
hsa0431023 | Prostate | Tumor | Wnt signaling pathway | 50/1791 | 171/8465 | 7.32e-03 | 2.37e-02 | 1.47e-02 | 50 |
hsa0431033 | Prostate | Tumor | Wnt signaling pathway | 50/1791 | 171/8465 | 7.32e-03 | 2.37e-02 | 1.47e-02 | 50 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SERPINF1 | SNV | Missense_Mutation | c.858N>C | p.Leu286Phe | p.L286F | P36955 | protein_coding | deleterious(0.04) | probably_damaging(0.985) | TCGA-A2-A0EQ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD | |
SERPINF1 | SNV | Missense_Mutation | rs762257275 | c.296N>A | p.Arg99Gln | p.R99Q | P36955 | protein_coding | tolerated(0.24) | benign(0.063) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SERPINF1 | SNV | Missense_Mutation | c.451N>C | p.Lys151Gln | p.K151Q | P36955 | protein_coding | deleterious(0.01) | possibly_damaging(0.51) | TCGA-AO-A0JB-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | cyclophosphamide | SD | |
SERPINF1 | insertion | Frame_Shift_Ins | c.324_325insCTCTCAGCAGACAAAAAAGATGAGTA | p.Tyr109LeufsTer13 | p.Y109Lfs*13 | P36955 | protein_coding | TCGA-AN-A0AL-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |||
SERPINF1 | SNV | Missense_Mutation | c.341N>A | p.Ser114Asn | p.S114N | P36955 | protein_coding | tolerated(0.92) | benign(0) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
SERPINF1 | SNV | Missense_Mutation | novel | c.668N>G | p.Ser223Cys | p.S223C | P36955 | protein_coding | deleterious(0.05) | possibly_damaging(0.797) | TCGA-MY-A913-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
SERPINF1 | SNV | Missense_Mutation | c.341G>A | p.Ser114Asn | p.S114N | P36955 | protein_coding | tolerated(0.92) | benign(0) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR | |
SERPINF1 | SNV | Missense_Mutation | c.852G>T | p.Gln284His | p.Q284H | P36955 | protein_coding | deleterious(0.02) | probably_damaging(0.966) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR | |
SERPINF1 | SNV | Missense_Mutation | novel | c.1216N>A | p.Leu406Ile | p.L406I | P36955 | protein_coding | deleterious(0.01) | probably_damaging(0.983) | TCGA-AA-A01D-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | capecitabine | PD |
SERPINF1 | SNV | Missense_Mutation | c.262N>A | p.Ala88Thr | p.A88T | P36955 | protein_coding | deleterious(0.01) | probably_damaging(0.978) | TCGA-AZ-6598-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
5176 | SERPINF1 | DRUGGABLE GENOME, PROTEASE INHIBITOR | AdPEDR | |||
5176 | SERPINF1 | DRUGGABLE GENOME, PROTEASE INHIBITOR | PEDF gene therapy |
Page: 1 |